pET28a-MH6-RspCas13d Citations (2)
Originally described in: Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.Yan WX, Chong S, Zhang H, Makarova KS, Koonin EV, Cheng DR, Scott DA Mol Cell. 2018 Mar 9. pii: S1097-2765(18)30173-4. doi: 10.1016/j.molcel.2018.02.028. PubMed Journal
Articles Citing pET28a-MH6-RspCas13d
| Articles |
|---|
| A strategy for Cas13 miniaturization based on the structure and AlphaFold. Zhao F, Zhang T, Sun X, Zhang X, Chen L, Wang H, Li J, Fan P, Lai L, Sui T, Li Z. Nat Commun. 2023 Sep 8;14(1):5545. doi: 10.1038/s41467-023-41320-8. PubMed |
| Intranasal drop of multiplex RNA therapy for SARS-CoV-2 infections: baicalein-enhanced FEN1 nuclease cleaving as a virus buster. Cao J, Wan M, Gu J, Wang P, Gao Y, Wei L, Guo Y, Zhao L, Xu S. Emerg Microbes Infect. 2026 Dec;15(1):2706349. doi: 10.1080/22221751.2026.2706349. Epub 2026 Aug 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.